PAR-23-158 - Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 5
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Advancing Research on SUD with brain-based computational models | NOT-DA-26-001 | NIDA | Jul 2, 2024 | Sep 8, 2027 | R01, R21, R61/R33, K01, R15, R03, K99/R00 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research | NOT-CA-22-037 | NCI NHLBI NIA NIDA NIMH NINR OBSSR | Jan 27, 2022 | Mar 9, 2024 | R01, R03, R21, R43/R44, R41/R42, R33, R34, R61/R33 |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects | NOT-OD-22-022 | ODP NIDCR NCI NIEHS NIDA | Dec 9, 2021 | May 9, 2023 | R01, R61/R33, R21, 333, R03 |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects | NOT-OD-22-023 | ODP NCI NIDA NIMHD NIDCR | Dec 8, 2021 | May 9, 2024 | R21, R01, 333, R34, R03, R61/R33 |
Notice of Special Interest (NOSI):Sleep and Substance Use Disorders | NOT-DA-20-021 | NIDA | Mar 25, 2020 | Sep 8, 2023 | R01, R03, R21, K99/R00, R61/R33 |